Lung cancer remains the leading cause of cancer deaths in the United States. In the past
decade, significant advances have been made in the science of non–small cell lung cancer …

Abstract Introduction/Background An individual patient data metaanalysis was performed to
determine clinical outcomes, and to propose a risk stratification system, related to the …

Background This guideline updates the second edition and addresses patients with
particular forms of non-small cell lung cancer that require special considerations, including …

This selection from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines)
for Non-Small Cell Lung Cancer (NSCLC) focuses on the principles of radiation therapy …

Oligometastases and oligo‐recurrence are among the most important notions of metastatic
and recurrent cancer. The concept of oligometastases is related to the notion that cancer …

Surgery remains the best curative option in patients with early stage lung cancer (stage I and
II). Developments in minimally invasive techniques now allow surgeons to perform lung …

Lung cancer is the primary reason of cancer deaths worldwide, and the percentage of death
rate is increasing step by step. There are chances of recovering from lung cancer by …

Introduction In most patients with NSCLC, the disease is diagnosed in an advanced stage,
the prognosis is poor, and survival is typically measured in months. Standard therapeutic …

Background We systematically reviewed the literature on the use of surgery, stereotactic
ablative body radiotherapy (SABR) and percutaneous catheter ablation (PCA) techniques …

Background Surgical treatment of patients with limited metastatic lesions from non-small cell
lung cancer (NSCLC) remains controversial; however, reports suggest that a subset of …